Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2)

Biochemical and Biophysical Research Communications

Volumn 233, Issue 3, 1997, Pages 579-583

  Wong, Chun Kwok ^a   Keung, Wing Ming ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL SULFOTRANSFERASE; DAIDZEIN; ENZYME INHIBITOR; HYDROXYSTEROID; STERYL SULFATASE; SULFATE; SULFOTRANSFERASE;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031589170     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6502     Document Type: Article

References (34)

1. Rose D. P., Boyar A. P., Wynder E. L. Cancer. 5:1986;671-687.
2. Adlercreutz H., Fotsis T., Heikkinen R. Lancet. 2:1982;1295-1299.
3. Adlercreutz H., Fotsis T., Bannwart C. J. Steroid Biochem. 25:1986;791-797.
4. Golden B. R., Adlercreutz H., Gorbach S. L., Woods M. N., Dwyer J. T., Conlon T., Bohn E., Gershoff S. N. Am. J. Clin. Nutr. 44:1986;945-953.
5. Barnes S., Grubbs C., Setchell K. D. R., Carlson J. Prog. Clin. Biol. Res. 347:1990;239-253.
6. Hawrylewicz E. J., Huang H. H., Blair W. H. J. Nutr. 121:1991;1639-1698.
7. American Cancer Society, 1993, Cancer Facts and Figures, Atlanta, GA.
8. Armstrong B., Doll R. Int. J. Cancer. 15:1975;617-631.
9. Lippman M. E. Endocrinology. 1989;Saunders, Philadelphia. p. 2706-2725.
10. Mäkelä S., Poutanen M., Lehtimaki J., Kosttian M.-L., Santti R., Vihko R. Proc. Soc. Exp. Biol. Med. 208:1995;51-59.
11. Wang C., Mäkelä T., Hase T., Adlercreutz H., Kurzer M. S. J. Steroid Biochem. Mol. Biol. 50:1994;205-212.
12. Santner S. J., Feil P. D., Santen R. J. J. Clin. Endocrinol. Metab. 59:1984;29-33.
13. Yamamoto T., Kitawaki J., Urabe M. J. Steroid Biochem. Molec. Biol. 44:1993;463-468.
14. Poortman J. Genazzani A. R., Thijssen J. H. H., Siiteri P. K. Adrenal Androgens. 1980;219-240 Raven, New York.
15. Bradford M. M. Anal. Biochem. 72:1976;248-254.
16. Suzuki T., Hirato K., Yanaihara T., Kadofuku T., Sato T., Hoshino M., Yanaihara N. Endocrinology (Japan). 39:1992;93-101.
17. Falany C. N., Vazquez M. E., Kalb J. M. Biochem. J. 260:1989;641-646.
18. Foldes A., Meek J. L. Biochim. Biophys. Acta. 327:1973;365-374.
19. Keung W. M., Vallee B. L. Proc. Natl. Acad. Sci. USA. 90:1993;10008-10012.
20. Powell G. M., White G. F., Curtis C. G., Rose F. A. Drug Metab. Drug Interact. 6:1988;203-2117.
21. Chang H. H-S., Robinson A. R., Common R. H. Can. J. Biochem. 53:1974;223-230.
22. Yasuda T., Kano Y., Saito K-I., Ohsawa K. Biol. Pharm. Bull. 17:1994;1369-1374.
23. Santner S. J., Santen R. J. J. Sterol Biochem. Mol. Biol. 45:1993;383-390.
24. Nguyen B.-L., Ferme I., Chetrite G., Pasqualini J. R. J. Sterol Biochem. Mol. Biol. 46:1993;17-23.
25. Chetrite G., Paris J., Botella J., Pasqualini J. R. J. Sterol Biochem. Mol. Biol. 58:1996;525-531.
26. Duncan L., Purohit A., Howarth N. M., Potter V. L., Reed M. J. Cancer Res. 53:1993;298-303.
27. Howarth N. M., Purohit A., Reed M. J., Potter V. L. J. Med. Chem. 37:1994;219-221.
28. Woo L. W. L., Purohit A., Reed M. J., Potter V. L. J. Med. Chem. 39:1996;1349-1351.
29. Carlstrom K., Doberl A., Ponsette A., Rannevik G., Wilking N. Acta Obstet. Gynecol. Scand. 123:1984;107-111.
30. Walle T., Eaton E. A., Walle U. K. Biochem. Pharmacol. 50:1995;731-734.
31. Bamforth K. J., Dalgliesh K., Coughtrie M. W. H. Eur. J. Pharmacol. 228:1992;15-21.
32. Majewska M. D. Prog. Neurobiol. 38:1992;379-395.
33. Keung W. M., Vallee B. L. EXS. 71:1994;371-381.
34. Heyman G. M., Keung W. M., Vallee B. L. Alcohol. Clin. Exp. Res. 20:1996;1083-1087.